Form 4: BioMarin Executive Cristin Hubbard Reports Stock Transactions

Cristin Hubbard, EVP and Chief Commercial Officer of BioMarin Pharmaceutical Inc., reports acquiring and disposing of company stock.

Summary

• Cristin Hubbard, an executive at BioMarin Pharmaceutical Inc., filed a Form 4 detailing changes in beneficial ownership.
• On April 30, 2025, Hubbard acquired 273 shares of common stock at a price of $54.137 per share through the Employee Stock Purchase Plan.
• On May 2, 2025, Hubbard disposed of 273 shares of common stock at a price of $64.92 per share.
• Following these transactions, Hubbard beneficially owns 32,700 shares of BioMarin common stock directly.
• The sale on May 2, 2025, was executed pursuant to a pre-arranged 10b5-1 trading plan established on September 13, 2024.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the filing simply reports routine stock transactions by an executive. The use of a 10b5-1 plan suggests the sale was pre-planned and not based on any recent material non-public information.

Positives

• The acquisition of shares through the Employee Stock Purchase Plan indicates confidence in the company.
• The sale was executed under a 10b5-1 plan, suggesting it was pre-planned and not based on insider information.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the trading activities of company insiders. These filings are closely watched by investors seeking insights into management's perspective on the company's stock.

Comparison to Industry Standards

• Executive stock transactions are common across publicly traded pharmaceutical companies.
• The use of 10b5-1 trading plans is a standard practice to avoid accusations of insider trading.
• Comparable companies such as Amgen, Gilead, and Vertex also have executives who regularly report stock transactions via Form 4 filings.

Stakeholder Impact

• The transactions may have a minor impact on shareholder sentiment, but are unlikely to significantly affect the stock price given the small number of shares involved and the use of a 10b5-1 plan.

Key Dates

Keywords

Form 4, BioMarin, BMRN, Insider Trading, Stock Transaction, Beneficial Ownership, Cristin Hubbard, 10b5-1 plan, Employee Stock Purchase Plan